Juan Miguel Mosquera

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities

  Science Advances · 2026-06-26

• Table S7 from Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition

  2026-06-17

• Table S6 from Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition

  2026-06-17

• Table S4 from Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition

  2026-06-17

• Table S5 from Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition

  2026-06-17

• Table S3 from Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition

  2026-06-17

• Table S2 from Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition

  2026-06-17

• Table S1 from Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition

  2026-06-17

• An International Survey Among Attending Urologists on the Term High‐Grade Prostatic Intraepithelial Neoplasia: Advocating for Removal of ‘High‐Grade’ From the Surgical Pathology Report

  International Journal of Urology · 2026-05-29

• Whole genome sequencing of locally advanced and metastatic breast carcinoma unravels relevant molecular signatures and novel events

  Pathology - Research and Practice · 2026-04-15

• Abstract A058: Integrating DNA-RNA sequencing analysis to identify low-variant allele frequency fusions in glioblastoma

  Cancer Research · 2026-03-23

• 19q13 amplification with AKT2 and ERCC2 gains in sarcomatoid carcinoma of the urinary bladder

  Cancer Genetics · 2026-03-11

• 891 Complex Structural Variants Associated with Homologous Recombination Deficiency in Advanced Prostate Cancer are Identified by Whole Genome Sequencing

  Laboratory Investigation · 2026-03-01

• 1474 Integrated Whole-Genome, Transcriptome and DNA Methylation Profiling in Rare and Challenging Tumors Arising in the Central Nervous System

  Laboratory Investigation · 2026-03-01

• 1486 Integrative Whole Genome and Transcriptome Characterization of Neuregulin 1 (NRG1) Alterations Across a Pan Cancer Cohort

  Laboratory Investigation · 2026-03-01

• 892 The Neuregulin 1 (NRG1)-HER2-HER3 Axis as a Therapeutic Target in Metastatic Castration-Resistant Prostate Cancer

  Laboratory Investigation · 2026-03-01

• 795 Expression of CEACAM5 and TROP2 in Advanced Prostate Cancer: Heterogeneity and Correlation with Morphologic and Immunophenotypic Subtypes

  Laboratory Investigation · 2026-03-01

• 796 Differential Expression of ASCL1, NEUROD1, and YAP1 in Neuroendocrine Prostate Cancer (NEPC) Suggests Potential Molecular Subtypes

  Laboratory Investigation · 2026-03-01

• 627 Comprehensive Characterization of NIPBL::NACC1 Fusion Hepatic Carcinoma: Further Evidence Supports a Distinct Entity

  Laboratory Investigation · 2026-03-01

• 839 Histologic Features “Suspicious for Extraprostatic Extension” on Core Biopsy Are Strongly Correlated with Extraprostatic Extension at Radical Prostatectomy

  Laboratory Investigation · 2026-03-01